Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Supreme Court Of India
2002 Gujarat Riots
Enforcement Directorate (ED)
Maharashtra Government
University Grants Commission
Alt News
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
India

Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension

Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Written by Abhishek Hari
Apr 29, 2022, 10:32 pm 2 min read
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
The WHO said it had halted the supply of COVAXIN to UN agencies due to recent GMP (good manufacturing practice) deficiencies.

The Ministry of External Affairs (MEA) on Friday denied reports that it had asked Bharat Biotech to address issues to avoid the cancellation of the World Health Organization's (WHO) emergency approval for its COVAXIN. The MEA said that "selective parts" of its "communication have been highlighted out of context to portray an incorrect picture."

Context
Why does this story matter?
  • The WHO announced on April 2 that it had decided to cancel the supply of COVAXIN via UN agencies in order to enable Bharat Biotech to address deficiencies in manufacturing practices discovered during an inspection.
  • The WHO, however, stated the vaccine was effective and safe, adding there was no "change in the risk-benefit ratio," but advised countries that received COVAXIN to "take appropriate actions."
MEA sources
It's an internal document, doesn't indicate MEA position: Sources

Reports claiming the MEA's alleged communication to Bharat Biotech referred "to an internal document circulated to members of the [Centre's] Empowered Group-5, which comprehensively looks at all issues related to vaccines," sources told ANI. They added the note only enlists different problems in a factual manner for the Empowered Group's consideration but doesn't indicate the MEA's stance or remark on any issue under review.

Media reports
What did the media reports say?

Recent reports cited an alleged MEA communication between Foreign Secretary Harsh Vardhan Shringla and the Empowered Group. Shringla said issues concerning vaccines used in the country and Indians' international travel have arisen, including the WHO's suspension of COVAXIN supplies and m-RNA-based booster requirements by several countries. He suggested Bharat Biotech address issues raised by the WHO to avoid the cancellation of COVAXIN's emergency approval.

Issue
What is so controversial about the communication?

The issue has become controversial as reports quoted Shringla as saying, "Bharat Biotech must address the matter immediately through DCGI and WHO and avoid any situation that may lead to cancellation of WHO's EUL (Emergency Use Listing) for COVAXIN." Notably, the MEA had also clarified earlier that the WHO's supply suspension will not affect travelers who had received the Bharat Biotech-manufactured COVID-19 vaccine.

Information
COVAXIN cleared for kids in 6-12 age group

Meanwhile, the Drugs Controller General of India (DCGI) on Tuesday granted further emergency use authorization to Bharat Biotech's COVAXIN for administration to kids in the 6-12 years age group and Biological E's Corbevax for the 5-12 age group as COVID-19 cases gradually rise in India.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Abhishek  Hari
Abhishek Hari
Mail
Abhishek Hari is a JRF holder in Political Science and is currently the National Writer at NewsBytes. He has previously worked as Sub-editor at The Wire and as a political researcher at the Lok Sabha Secretariat. Hindu College, University of Delhi, and Jamia Millia Islamia are his alma mater. In his free time, he loves to play the drums and listen to classic rock and roll music.
Latest
World Health Organization
Ministry Of External Affairs
COVID-19
Bharat Biotech
COVAXIN
Related
Latest
Jos Buttler announced as England's white-ball captain: Details here
Jos Buttler announced as England's white-ball captain: Details here Sports
Decoding the 2022 summer transfer window plans of AS Roma
Decoding the 2022 summer transfer window plans of AS Roma Sports
5 reasons you must have kadha every day
5 reasons you must have kadha every day Lifestyle
'Kingmaker' to 'King' of Maharashtra: Meet CM Eknath Shinde
'Kingmaker' to 'King' of Maharashtra: Meet CM Eknath Shinde Politics
5 ways to treat your feet right this monsoon
5 ways to treat your feet right this monsoon Lifestyle
World Health Organization
US to distribute monkeypox vaccines nationwide to curb outbreak
US to distribute monkeypox vaccines nationwide to curb outbreak World
COVID-19 vaccines prevented 42L deaths in India in 2021: Report
COVID-19 vaccines prevented 42L deaths in India in 2021: Report India
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
India's air pollution reducing 5 years of life expectancy: Study
India's air pollution reducing 5 years of life expectancy: Study India
New Google Map feature shows air quality index around you
New Google Map feature shows air quality index around you Technology
More News
Ministry Of External Affairs
Germany: Energy, climate change top PM Modi's G7 summit agenda
Germany: Energy, climate change top PM Modi's G7 summit agenda World
Meet Ruchira Kamboj, India's next Permanent Representative to UN
Meet Ruchira Kamboj, India's next Permanent Representative to UN India
PM Modi to visit Germany, UAE next week
PM Modi to visit Germany, UAE next week India
Maldives: Mob storms International Yoga Day event; probe ordered
Maldives: Mob storms International Yoga Day event; probe ordered World
Jaishankar on Prophet row: People's sensibilities and sensitivities were impacted
Jaishankar on Prophet row: People's sensibilities and sensitivities were impacted India
More News
COVID-19
How to make the best of work from home
How to make the best of work from home Lifestyle
Education Ministry: No change in NEET-UG, CUET, JEE (Main) schedule
Education Ministry: No change in NEET-UG, CUET, JEE (Main) schedule Career
Maharashtra: How 'people's officer' Mittali Sethi transforming children's education, sanitation
Maharashtra: How 'people's officer' Mittali Sethi transforming children's education, sanitation Inspirational
COVID-19: India logs 14,506 fresh cases, 30 more fatalities
COVID-19: India logs 14,506 fresh cases, 30 more fatalities India
COVID-19: India logs 11,793 new cases, 27 more deaths
COVID-19: India logs 11,793 new cases, 27 more deaths India
More News
Bharat Biotech
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
Are Indian vaccines effective against Omicron? Here's what manufacturers say
Are Indian vaccines effective against Omicron? Here's what manufacturers say India
COVAXIN gets WHO approval for emergency use listing
COVAXIN gets WHO approval for emergency use listing India
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers World
More News
COVAXIN
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced India
COVAXIN found 50% effective against COVID-19 in first real-world study
COVAXIN found 50% effective against COVID-19 in first real-world study India
More News
Related
RBI fake currency report: Opposition's demonetization swipe at Modi government
RBI fake currency report: Opposition's demonetization swipe at Modi government Business
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022